A randomized double blind multicentric placebo controlled phase III study assessing the efficacy and safety of intra articular administration Stem peucel(adult human bone marrow derived, cultured , pooled , allogenic mesenchymal stromal cells) in patients with osteoarthritis of knee
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2018 - 2020
Project Lead
Authors
Dr Joe Joseph cherian, Dr Jovis Johny
Project Status
completed
Project Type
clinical trial